Results 151 to 160 of about 86,994 (313)

Structural snapshots capture nucleotide release at the μ-opioid receptor. [PDF]

Nature
Khan S, Tyson AS, Ranjbar M, Zhang Z, Singh J, Han GW, Gati C.   +6 more
europepmc   +1 more source

Regulator of G protein signaling proteins differentially modulate signaling of μ and δ opioid receptors

, 2007
Zhihua Xie, Zhisong Li, Lei Guo, Caiying Ye, Juan Li, Xiaoli Yu, Huifen Yang, Yulin Wang, Chongguang Chen, Dechang Zhang, Lee‐Yuan Liu‐Chen   +10 more
openalex   +1 more source

Minimally invasive sacroiliac joint fusion: Primary endpoint results from the prospective, multicenter STACI study

PM&R, EarlyView.
Abstract Background Chronic sacroiliac joint (SIJ) pain is highly debilitating. Minimally invasive SIJ fusion has become a commonly performed surgical treatment for SIJ pain, with level I evidence showing clinically significant improvements in pain, function, and quality of life and a low adverse event rate.
Jacqueline Weisbein, Timothy Davis, Douglas Beall, Jack Smith, Caroline Harstroem, Daniel Kloster, Morteza Rabii, Robyn Capobianco, Ramana Naidu, Michael Harned, Christopher Mallard, the STACI investigators   +11 more
wiley   +1 more source

Emotion processing in schizophrenia and its relation to μ-opioid receptor availability. [PDF]

Neuroimage Clin
Shatalina E, Ashok AH, Wall MB, Myers J, Marques TR, Rabiner EA, Howes OD.   +6 more
europepmc   +1 more source

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects

, 2012
H.A. Moynihan, Ian Derrick, Jillian H. Broadbear, Benjamin Greedy, Mario D. Aceto, Louis S. Harris, Lauren C. Purington, Mark Thomas, James H. Woods, John R. Traynor, Stephen M. Husbands, John W. Lewis   +11 more
openalex   +2 more sources

Regulation of Opioid Receptor Trafficking and Signaling by Opioid Peptides

, 2021
Jennifer M. Kunselman
openalex   +2 more sources

Intranasal diamorphine population pharmacokinetics modeling and simulation in pediatric breakthrough pain

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 435-447, March 2025.
Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai, Jingchen Zhai, Beihong Ji, Fengyang Han, Taoyu Niu, Luxuan Wang, Junmei Wang   +6 more
wiley   +1 more source

Casomorphine-10 (CM-10) Peptide Orchestrates Circadian and Neurodevelopmental Gene Clusters via δ-Opioid Receptor Signaling: Insights from Transcriptome Analysis with δ-Opioid Receptor-Expressing HEK293 Cells. [PDF]

Life (Basel)
Fukunaga M, Watanabe S, Orihara K, Yamamoto N.   +3 more
europepmc   +1 more source

Smoking Modulation of μ-Opioid and Dopamine D2 Receptor-Mediated Neurotransmission in Humans [PDF]

, 2006
David Scott, Edward F. Domino, Mary M. Heitzeg, Robert A. Koeppe, Lisong Ni, Sally K. Guthrie, Jon‐Kar Zubieta   +6 more
openalex   +1 more source

Population Pharmacokinetics and Transfer of Gabapentin When Used as a Pain Adjunct for Cesarean Deliveries

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 551-560, March 2025.
ABSTRACT Enhanced Recovery After Surgery (ERAS) protocols for cesarean deliveries (CDs) utilize multimodal pain management strategies that often include gabapentin. While gabapentin is excreted in breast milk, its pharmacokinetics in immediately postpartum lactating women are not known. This observational pharmacokinetic study (NCT05099484) enrolled 21
Rebecca Silvola, Aislinn O'Kane, Michael Heathman, Hannah Marotta, Hayley Trussel, Bobbie Ray, Shelley Dowden, Andrea R. Masters, David M. Haas, Sara K. Quinney   +9 more
wiley   +1 more source